Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization.
2020 saw significant disruption to the drug development and clinical trials landscape in Australia and around the world. Australia’s response was remarkable in its ability to respond to the challenges and capture opportunities. How we maintain that momentum and build upon this is an important theme for discussion in 2021.
Ongoing work is needed to drive Australia to become globally competitive in novel therapeutics and create better pathways for companies to translate their great research into commercial products. From effective early partnering to funding plans for translation and commercialisation – this event is a critical opportunity for dialogue and debate between key stakeholders.
Australia is now well known as a leading destination for early phase clinical trials. The next step is to ensure we maintain the efficiencies and innovations adopted during the pandemic and build upon them. What are the innovative models which can be adopted and sustained? What are the opportunities with new tech and devices within clinical trials and what are the regulatory considerations?
Our communities are keen to reconnect, network, and learn more than ever after months of disruption. We are excited to be moving back to in-person events but will continue to offer the option to attend the event virtually.
Key topics to be covered in 2021:
- Best practice examples in maturing assets and taking discoveries into clinic the right way
- Emerging technology and remote monitoring in clinical trials
- Devices in clinical trials
- Manufacturing capabilities in Australia – exploring what’s needed and where opportunities lie
- Creating efficiencies – models to bring the right patient to the right trial and increasing recruitment to studies
- Learnings from the efficiencies achieved with covid vaccine pipeline – can we apply this to other therapeutics?
- Trials in primary heath and GP Health network settings
- Virtual trials and teletrials in Australia
- Home based trials and hospital in the home
- The clinical trials governance framework in Australia
- Sustainability into clinical trial units in rural and regional areas
- The post-covid investment landscape
- Breakthrough Victoria Fund to boost research & innovation
- Clinical Trial Diversity and Inclusion
The Hon John Brumby AO
Chancellor, La Trobe University, Chairman and Director, BioCurate, Chair, Breakthrough Victoria Fund
David Thomas FRACP
Phd, Head, Genomic Cancer Medicine, Garvan Institute of Medical Research, Director, The Kinghorn Cancer Centre & Chief Executive Officer, Omico: Australian Genomic Cancer Medicine Centre
Dr Anand Gautam
Executive Director & Emerging Science Lead, Emerging Science & Innovation, Asia & APAC (Australia & New Zealand), Pfizer Worldwide R&D
Director of Technology Strategy and Policy, Department of Premier and Cabinet, Government of South Australia
Executive Chairman, Grey Innovation Group
Dr Mark Ashton
Executive Director, IP Commercialisation, UniQuest
Associate Professor Tam C. Nguyen
Deputy Director of Research, St Vincent's Hospital Melbourne
Managing Director, Australia, Lumira Ventures
Anita van der Meer
Manager, clinicaltrialsNSW | Office for Health and Medical Research, NSW Ministry of Health
Dr Tina Soulis
Founder and Director, Alithia Life Sciences
Co-Founder & CEO, oNKo-innate
Chief Operating Officer and Company Secretary, BioCurate Pty Ltd
Dr Deborah Rathjen
CEO, Carina Biotech
Director, Clinical Pharmacology & Translational Development Operations, CSL
Dr John Patava
Chief Operating Officer, AUM Biosciences
Executive Director Clinical Trials, Ingham Institute, South Western Sydney Local Health District
Early Phase Clinical Trial Manager, Bellberry Limited
Dr. Russell Tait
CEO, PolyActiva Pty. Ltd
GM Business Development, Luina Bio
Senior Director of Business and Corporate Development, Asia Pacific, Illingworth Research Group a Syneos Health Company
Professor Ian Alexander
Clinical Geneticist, FAHMS, Director Laboratory Research and Senior Staff Specialist, The Children’s Hospital at Westmead, Professor in Paediatrics and Molecular Medicine, University of Sydney & Head of the Gene Therapy Research Unit, a joint initiative of Children’s Medical Research Institute and The Children’s Hospital at Westmead (CHW)
Dr Ric DeGaris
Interim CEO / Head, Clinical Operations, Neuroscience Trials Australia
Chief Strategy Officer, Avance Clinical
Professor Sally McArthur
Co-Director, MedTechVic & Director, Manufacturing Futures Research Institute
Founder and Managing Director, Medicines Development for Global Health
CEO, WeGuide & MD, Curve Group
Bio Palooza is back for 2021!
We are delighted to announce the event highlight Bio Palooza Dinner will be returning for the 2021 edition of Bio Connections Australia. Don’t miss out on this intimate get together and key networking opportunity to further discuss and connect following the conference with your fellow delegates and speakers in this informal setting.
Health & Safety Commitments
When you join our event, you can expect to see that health and safety is a priority, and that a range of measures are in place to ensure everyone involved is able to enjoy a safe, hygienic, productive and high-quality organised event experience.
All Informa events will be run according to official government and local authority guidance in the first instance, as well as any venue or location-specific regulations. In addition, Informa Australia will follow some key health and safety priority commitments as part of “Informa AllSecure“.
Full vaccination against Covid-19 is required for all in-person attendees.
IMPORTANT: For more information on Informa’s Vaccination requirement for all in-person attendees, our Event Health & Safety measures in place and Conditions of entry, click here.
Our Commitment to Sustainability
In Australia, we are committed to running our events in an environmentally and socially responsible way. Across Informa Connect we are focusing on the short and long-term sustainability impacts we have on customers and colleagues alongside the communities we work in.
We recognise that it’s not just about the way we produce our events and products but recognising that we have a role to play in providing a space to work in partnership together with our markets to inspire the sustainable development of the industries we serve.
To read more on our latest sustainability reports and Faster Forward initiatives – click here.